Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma

Chinese Journal of Pathology

Volumn 36, Issue 2, 2007, Pages 113-117

  Chen, Gang ^b   Luo, Dian Zhong ^a   Wang, Yun ^b   Liao, Zhi Ling ^b   Zhang, Mei Yan ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Apoptosis; Carcinoma; Hepatocellular; Immunohistochemistry

Indexed keywords

ALPHA FETOPROTEIN; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; DNA NUCLEOTIDYLEXOTRANSFERASE; MEMBRANE PROTEIN; PROTEIN DCR3; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; DEMOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METASTASIS; NICK END LABELING; PORTAL VEIN; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TUMOR EMBOLISM;

ADULT; AGED; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 34047174035     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer, 2002,2(6):420-430.
2. Chang YC, Chan YH, Jackson DG, et al. The glycosaminoglycanbinding domain of decoy receptor 3 is essential for induction of monocyte adhesion. J Immunol, 2006,176(1):173-180.
3. Shi G, Luo H, Wan X, et al. Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood, 2002, 100 (9):3279-3286.
4. Wroblewski VJ, Witcher DR, Becker GW, et al. Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT. Biochem Pharmacol, 2003,65(4):657-667.
5. Pitti RM, Marsters SA, Lawrence DA, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature, 1998,396(6712):699-703.
6. Takahama Y, Yamada Y, Emoto K, et al. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas. Gastric Cancer, 2002,5(2):61-68.
7. Tsuji S, Hosotani R, Yonehara S, et al. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma. Int J Cancer, 2003, 106(1):17-25.
8. Hamilton SR, Aaltonen LA. World Health Organization classification of tumors. Pathology and genetics of tumors of the digestive system. Lyon; IARC Press, 2000.
9. Chinese source
10. Bai C, Connolly B, Metzker ML, et al. Overexpression of M68/ DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci U S A, 2000,97(3):1230-1235.
11. Roth W, Isenmann S, Nakamura M, et al. Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res, 2001,61(6): 2759-2765.
12. Arakawa Y, Tachibana O, Hasegawa M, et al. Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma. Acta Neuropathol (Berl) , 2005,109(3):294-298.
13. Ohshima K, Haraoka S, Sugihara M, et al. Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas. Cancer Lett, 2000,160 (1):89-97.
14. Li H, Zhang L, Lou H, et al. Overexpression of decoy receptor 3 in precancerous lesions and adenocarcinoma of the esophagus. Am J Clin Pathol, 2005,124(2):282-287.
15. Shen HW, Gao SL, Wu YL, et al. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis. World J Gastroenterol, 2005,11(38):5926-5930.
16. Chinese source